{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:45:11Z","timestamp":1782740711721,"version":"3.54.5"},"reference-count":96,"publisher":"Elsevier","isbn-type":[{"value":"9780443471001","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.acc.2026.03.001","type":"book-chapter","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T21:41:52Z","timestamp":1775598112000},"page":"47-84","source":"Crossref","is-referenced-by-count":0,"title":["RNA biomarkers in antidoping"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0388-1352","authenticated-orcid":false,"given":"Olivier","family":"Salamin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiia","family":"Kuuranne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7106-6304","authenticated-orcid":false,"given":"Nicolas","family":"Leuenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.acc.2026.03.001_bib0001","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.forsciint.2007.04.001","article-title":"From population- to subject-based limits of T\/E ratio to detect testosterone abuse in elite sports","volume":"174","author":"Sottas","year":"2008","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/bs.acc.2026.03.001_bib0002","doi-asserted-by":"crossref","first-page":"791","DOI":"10.4155\/bio-2020-0035","article-title":"Biomarkers of doping: uses, discovery and validation","volume":"12","author":"Aikin","year":"2020","journal-title":"Bioanalysis"},{"key":"10.1016\/bs.acc.2026.03.001_bib0003","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1373\/clinchem.2011.162271","article-title":"The athlete biological passport","volume":"57","author":"Sottas","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2026.03.001_bib0004","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1210\/clinem\/dgad085","article-title":"Longitudinal profiling of endogenous steroids in blood using the athlete biological passport approach","volume":"108","author":"Equey","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2026.03.001_bib0005","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1210\/clinem\/dgab799","article-title":"Application of the athlete biological passport approach to the detection of growth hormone doping","volume":"107","author":"Equey","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2026.03.001_bib0006","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1074\/mcp.M400007-MCP200","article-title":"How industry is approaching the search for new diagnostic markers and biomarkers","volume":"3","author":"Zolg","year":"2004","journal-title":"Mol. Cell Proteomics MCP"},{"key":"10.1016\/bs.acc.2026.03.001_bib0007","first-page":"9.23.1","article-title":"Biomarkers: a general review","volume":"76","author":"Aronson","year":"2017","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/bs.acc.2026.03.001_bib0008","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fphys.2020.00160","article-title":"Prevalence estimate of blood doping in elite track and field athletes during two major international events","volume":"11","author":"Faiss","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/bs.acc.2026.03.001_bib0009","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1373\/clinchem.2010.156067","article-title":"Prevalence of blood doping in samples collected from elite track and field athletes","volume":"57","author":"Sottas","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2026.03.001_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/dta.2773","article-title":"Antidoping: from health tests to the athlete biological passport","author":"Saugy","year":"2020","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0011","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/dta.173","article-title":"Implementation of the biological passport: the experience of the International Cycling Union","volume":"2","author":"Zorzoli","year":"2010","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0012","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.4155\/bio.09.87","article-title":"Biomarkers: unrealized potential in sports doping analysis","volume":"1","author":"Teale","year":"2009","journal-title":"Bioanalysis"},{"key":"10.1016\/bs.acc.2026.03.001_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcmd.2014.02.009","article-title":"The RNA in reticulocytes is not just debris: it is necessary for the final stages of erythrocyte formation","volume":"53","author":"Lee","year":"2014","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/bs.acc.2026.03.001_bib0014","first-page":"991","article-title":"Analysis of human reticulocyte genes reveals altered erythropoiesis: potential use to detect recombinant human erythropoietin doping","volume":"89","author":"Varlet-Marie","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/bs.acc.2026.03.001_bib0015","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/ajh.21525","article-title":"Modification of gene expression: help to detect doping with erythropoiesis-stimulating agents","volume":"84","author":"Varlet-Marie","year":"2009","journal-title":"Am. J. Hematol."},{"key":"10.1016\/bs.acc.2026.03.001_bib0016","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1152\/physiolgenomics.00108.2015","article-title":"Blood transcriptional signature of recombinant human erythropoietin administration and implications for antidoping strategies","volume":"48","author":"Durussel","year":"2016","journal-title":"Physiol. Genomics"},{"key":"10.1016\/bs.acc.2026.03.001_bib0017","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1186\/s12864-017-4191-7","article-title":"Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration","volume":"18","author":"Wang","year":"2017","journal-title":"BMC Genomics"},{"key":"10.1016\/bs.acc.2026.03.001_bib0020","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1373\/clinchem.2019.306829","article-title":"Detection of stimulated erythropoiesis by the RNA-based 5\u2019-aminolevulinate synthase 2 biomarker in dried blood spot samples","volume":"65","author":"Salamin","year":"2019","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2026.03.001_bib0021","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/dta.3123","article-title":"The use of RNA-based 5\u2019-aminolevulinate synthase 2 biomarkers in dried blood spots to detect recombinant human erythropoietin microdoses","volume":"14","author":"Loria","year":"2022","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0022","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/dta.3665","article-title":"mRNA biomarkers sensitive and specific to micro-dose erythropoietin treatment at sea level and altitude","volume":"16","author":"Loria","year":"2024","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0023","doi-asserted-by":"crossref","DOI":"10.1002\/dta.3870","article-title":"RNA-based biomarkers of iron metabolism in dried blood spots for detecting recombinant human erythropoietin in doping control","author":"Liu","year":"2025","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0025","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1423-0410.2009.01169.x","article-title":"Gene expression in the detection of autologous blood transfusion in sports\u2014a pilot study","volume":"96","author":"Pottgiesser","year":"2009","journal-title":"Vox Sang."},{"key":"10.1016\/bs.acc.2026.03.001_bib0018","doi-asserted-by":"crossref","first-page":"E460","DOI":"10.1002\/ajh.24470","article-title":"Impact of blood transfusion on gene expression in human reticulocytes","volume":"91","author":"Salamin","year":"2016","journal-title":"Am. J. Hematol."},{"key":"10.1016\/bs.acc.2026.03.001_bib0019","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/dta.2240","article-title":"Transcriptomic biomarkers of altered erythropoiesis to detect autologous blood transfusion","volume":"10","author":"Salamin","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0026","doi-asserted-by":"crossref","DOI":"10.1002\/dta.3939","article-title":"mRNA biomarkers in dried blood spots may improve detection of autologous blood micro-transfusions using an individualized approach","author":"Andersen","year":"2025","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0024","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/dta.3407","article-title":"The effects of iron injection on blood doping biomarkers in dried blood spots","volume":"15","author":"Loria","year":"2023","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0027","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1210\/jc.2009-1038","article-title":"Detection of growth hormone doping by gene expression profiling of peripheral blood","volume":"94","author":"Mitchell","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2026.03.001_bib0028","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jpba.2016.05.022","article-title":"Genetic and protein biomarkers in blood for the improved detection of GH abuse","volume":"128","author":"Ferro","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0029","unstructured":"Partnership for Clean Competition Funded projects. (2019). https:\/\/cleancompetition.org\/funded-projects\/. (Accessed 21 Aug 2025)"},{"key":"10.1016\/bs.acc.2026.03.001_bib0030","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12920-023-01512-z","article-title":"An observational human study investigating the effect of anabolic androgenic steroid use on the transcriptome of skeletal muscle and whole blood using RNA-Seq","volume":"16","author":"Kolliari-Turner","year":"2023","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/bs.acc.2026.03.001_bib0031","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","article-title":"microRNAs in action: biogenesis, function and regulation","volume":"24","author":"Shang","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/bs.acc.2026.03.001_bib0032","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/dta.370","article-title":"Circulating microRNAs as long-term biomarkers for the detection of erythropoiesis-stimulating agent abuse","volume":"3","author":"Leuenberger","year":"2011","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0033","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1537-2995.2010.02585.x","article-title":"Differential profiling of human red blood cells during storage for 52 selected microRNAs","volume":"50","author":"Kannan","year":"2010","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/bs.acc.2026.03.001_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066309","article-title":"Circulating microRNAs as biomarkers for detection of autologous blood transfusion","volume":"8","author":"Leuenberger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2026.03.001_bib0035","unstructured":"Donati, F., Boccia, F., Stampella, A., de la Torre, X., Botr\u00e8, F. MicroRNA Analysis for the Detection of Autologous Blood Transfusion in Doping Control. Recent Advances in Doping Analysis (22) : Proceedings of the Manfred-Donike-Workshop ; 32nd Cologne Workshop on Dope Analysis ; 30th March to 4th April 2014 2014: S. 89-92."},{"key":"10.1016\/bs.acc.2026.03.001_bib0036","doi-asserted-by":"crossref","DOI":"10.1136\/bmjsem-2018-000354","article-title":"Changes in the microRNA expression profile during blood storage","volume":"4","author":"Haberberger","year":"2018","journal-title":"BMJ Open Sport. Exerc. Med."},{"key":"10.1016\/bs.acc.2026.03.001_bib0037","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1111\/trf.15383","article-title":"Altered erythroid-related miRNA levels as a possible novel biomarker for detection of autologous blood transfusion misuse in sport","volume":"59","author":"Gasparello","year":"2019","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/bs.acc.2026.03.001_bib0038","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ajh.26078","article-title":"On the trail of blood doping-microRNA fingerprints to monitor autologous blood transfusions in vivo","volume":"96","author":"Mussack","year":"2021","journal-title":"Am. J. Hematol."},{"key":"10.1016\/bs.acc.2026.03.001_bib0039","first-page":"189","article-title":"Detection of hypoxia-regulated MicroRNAs in blood as potential biomarkers of HIF stabilizer molidustat","volume":"8","author":"Marchand","year":"2019","journal-title":"MicroRNA Shariqah United Arab. Emir."},{"key":"10.1016\/bs.acc.2026.03.001_bib0040","doi-asserted-by":"crossref","DOI":"10.47529\/2223-2524.2023.4.8","article-title":"MiR-378a-3p and miR-491-5p as markers of xenon abuse in doping control","author":"Postnikov","year":"2024","journal-title":"Sports Med. Res. Pract."},{"key":"10.1016\/bs.acc.2026.03.001_bib0041","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/dta.1469","article-title":"Circulating microRNA as a biomarker of human growth hormone administration to patients","volume":"6","author":"Kelly","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0042","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/dta.2506","article-title":"Longitudinally monitoring of P-III-NP, IGF-I, and GH-2000 score increases the probability of detecting two weeks\u2019 administration of low-dose recombinant growth hormone compared to GH-2000 decision limit and GH isoform test and micro RNA markers","volume":"11","author":"Lehtihet","year":"2019","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155248","article-title":"Circulating microRNA-122 as potential biomarker for detection of testosterone abuse","volume":"11","author":"Salamin","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2026.03.001_bib0044","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/dta.2341","article-title":"Sensitivity of doping biomarkers after administration of a single dose testosterone gel","volume":"10","author":"Mullen","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0045","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/978-3-319-22671-2_20","article-title":"Circulating microRNAs: the future of biomarkers in anti-doping field","volume":"888","author":"Leuenberger","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/bs.acc.2026.03.001_bib0046","first-page":"25","article-title":"Circulating MicroRNAs as a new class of biomarkers of physiological reactions of the organism to the intake of dietary supplements and drugs","volume":"11","author":"Postnikov","year":"2022","journal-title":"MicroRNA Shariqah United Arab. Emir."},{"key":"10.1016\/bs.acc.2026.03.001_bib0047","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/ijms25010249","article-title":"Whispers in the blood: leveraging MicroRNAs for unveiling autologous blood doping in athletes","volume":"25","author":"Hassanpour","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.acc.2026.03.001_bib0048","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/dta.370","article-title":"Circulating microRNAs as long-term biomarkers for the detection of erythropoiesis-stimulating agent abuse","volume":"3","author":"Leuenberger","year":"2011","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0049","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1084\/jem.20100458","article-title":"The miR-144\/451 locus is required for erythroid homeostasis","volume":"207","author":"Rasmussen","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/bs.acc.2026.03.001_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066309","article-title":"Circulating microRNAs as biomarkers for detection of autologous blood transfusion","volume":"8","author":"Leuenberger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2026.03.001_bib0051","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.tmrv.2016.05.007","article-title":"Autologous blood transfusion in sports: emerging biomarkers","volume":"30","author":"Salamin","year":"2016","journal-title":"Transfus. Med. Rev."},{"key":"10.1016\/bs.acc.2026.03.001_bib0052","first-page":"189","article-title":"Detection of hypoxia-regulated MicroRNAs in blood as potential biomarkers of HIF stabilizer molidustat","volume":"8","author":"Marchand","year":"2019","journal-title":"MicroRNA Shariqah United Arab. Emir."},{"key":"10.1016\/bs.acc.2026.03.001_bib0053","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/jcb.24745","article-title":"Standardizing analysis of circulating microRNA: clinical and biological relevance","volume":"115","author":"Farina","year":"2014","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/bs.acc.2026.03.001_bib0054","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/s41598-019-38505-x","article-title":"Normalization strategies differently affect circulating miRNA profile associated with the training status","volume":"9","author":"Faraldi","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.acc.2026.03.001_bib0055","unstructured":"World Anti Doping Agency World antidoping agency technical document for dried blood spots\u2014TD2023DBS. World Anti Doping Agency. (2022) https:\/\/www.wada-ama.org\/en\/resources\/lab-documents\/td2023dbs. (Accessed 8 September 2025)"},{"key":"10.1016\/bs.acc.2026.03.001_bib0056","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/dta.1646","article-title":"Dried blood spots: concepts, present status, and future perspectives in bioanalysis","volume":"6","author":"Sharma","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0057","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1542\/peds.32.3.338","article-title":"A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants","volume":"32","author":"Guthrie","year":"1963","journal-title":"Pediatrics"},{"key":"10.1016\/bs.acc.2026.03.001_bib0058","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/dta.3142","article-title":"A fast screening method for the detection of CERA in dried blood spots","volume":"14","author":"Rocca","year":"2022","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0059","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/dta.2108","article-title":"Evaluation of fibronectin 1 in one dried blood spot and in urine after rhGH treatment","volume":"9","author":"Ferro","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0060","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/dta.3889","article-title":"Analysis of testosterone esters in serum and DBS samples-results from an Interlaboratory study","volume":"17","author":"Langer","year":"2025","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114280","article-title":"Steroid profiling by UHPLC-MS\/MS in dried blood spots collected from healthy women with and without testosterone gel administration","volume":"204","author":"Salamin","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0062","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/dta.3030","article-title":"Stability and detectability of testosterone esters in dried blood spots after intramuscular injections","volume":"14","author":"Solheim","year":"2022","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0063","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1373\/clinchem.2019.306829","article-title":"Detection of stimulated erythropoiesis by the RNA-based 5\u2019-aminolevulinate synthase 2 biomarker in dried blood spot samples","volume":"65","author":"Salamin","year":"2019","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2026.03.001_bib0064","doi-asserted-by":"crossref","DOI":"10.1002\/dta.3939","article-title":"mRNA biomarkers in dried blood spots may improve detection of autologous blood micro-transfusions using an individualized approach","author":"Andersen","year":"2025","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0065","doi-asserted-by":"crossref","first-page":"729","DOI":"10.4155\/bio-2020-0041","article-title":"Automation of RNA-based biomarker extraction from dried blood spots for the detection of blood doping","volume":"12","author":"Loria","year":"2020","journal-title":"Bioanalysis"},{"key":"10.1016\/bs.acc.2026.03.001_bib0066","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/dta.3135","article-title":"No pain, just gain: painless, easy, and fast dried blood spot collection from fingertip and upper arm in doping control","volume":"13","author":"Solheim","year":"2021","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0067","doi-asserted-by":"crossref","DOI":"10.3389\/fspor.2024.1452079","article-title":"Comparison between standard hematological parameters and blood doping biomarkers in dried blood spots within the athlete population of Swiss Sport Integrity","volume":"6","author":"Oliveira","year":"2024","journal-title":"Front. Sports Act Living"},{"key":"10.1016\/bs.acc.2026.03.001_bib0068","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.tmrv.2016.05.007","article-title":"Autologous blood transfusion in sports: emerging biomarkers","volume":"30","author":"Salamin","year":"2016","journal-title":"Transfus. Med. Rev."},{"key":"10.1016\/bs.acc.2026.03.001_bib0069","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/dta.3665","article-title":"mRNA biomarkers sensitive and specific to micro-dose erythropoietin treatment at sea level and altitude","volume":"16","author":"Loria","year":"2024","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0070","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/dta.3123","article-title":"The use of RNA-based 5\u2019-aminolevulinate synthase 2 biomarkers in dried blood spots to detect recombinant human erythropoietin microdoses","volume":"14","author":"Loria","year":"2022","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0071","unstructured":"World Antidoping Agency\u2014Laboratory Guidelines Gene doping detection based on polymerase chain reaction (PCR). (2021). https:\/\/www.wada-ama.org\/en\/resources\/laboratory-guidelines-gene-doping-detection-based-polymerase-chain-reaction-pcr. (Accessed 6 October 2025)"},{"key":"10.1016\/bs.acc.2026.03.001_bib0072","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/ajh.26368","article-title":"Tracking immature reticulocyte proteins for improved detection of recombinant human erythropoietin (rhEPO) abuse","volume":"96","author":"Cox","year":"2021","journal-title":"Am. J. Hematol."},{"key":"10.1016\/bs.acc.2026.03.001_bib0073","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/dta.2323","article-title":"Detection of autologous blood transfusions using a novel dried blood spot method","volume":"9","author":"Cox","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0074","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/ajh.26368","article-title":"Tracking immature reticulocyte proteins for improved detection of recombinant human erythropoietin (rhEPO) abuse","volume":"96","author":"Cox","year":"2021","journal-title":"Am. J. Hematol."},{"key":"10.1016\/bs.acc.2026.03.001_bib0075","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s40798-023-00662-9","article-title":"Age-markers on the red blood cell surface and erythrocyte microparticles may constitute a multi-parametric strategy for detection of autologous blood transfusion","volume":"9","author":"Biasini","year":"2023","journal-title":"Sports Med. Open"},{"key":"10.1016\/bs.acc.2026.03.001_bib0076","doi-asserted-by":"crossref","first-page":"R152","DOI":"10.1152\/ajpregu.00070.2021","article-title":"Effects of altitude and recombinant human erythropoietin on iron metabolism: a randomized controlled trial","volume":"321","author":"Breenfeldt Andersen","year":"2021","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/bs.acc.2026.03.001_bib0077","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1249\/MSS.0000000000002950","article-title":"Hepcidin and erythroferrone complement the athlete biological passport in the detection of autologous blood transfusion","volume":"54","author":"Breenfeldt Andersen","year":"2022","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/bs.acc.2026.03.001_bib0078","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/dta.2122","article-title":"Hepcidin as a potential biomarker for blood doping","volume":"9","author":"Leuenberger","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0079","doi-asserted-by":"crossref","DOI":"10.1002\/dta.3943","article-title":"Identification of candidate blood biomarkers of recombinant human erythropoietin administration using targeted polar metabolomics by HILIC-MS\/MS","author":"Salamin","year":"2025","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0080","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1097\/JSM.0000000000001074","article-title":"Metabolomic profiling of recombinant erythropoietin (rHuEpo) in trained Caucasian athletes","volume":"33","author":"Lima","year":"2023","journal-title":"Clin. J. Sport Med."},{"key":"10.1016\/bs.acc.2026.03.001_bib0081","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3390\/metabo12050425","article-title":"Untargeted metabolomics identifies a novel panel of markers for autologous blood transfusion","volume":"12","author":"Al-Nesf","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/bs.acc.2026.03.001_bib0082","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4155\/bio-2021-0252","article-title":"Monitoring of hemoglobin and erythropoiesis-related mRNA with dried blood spots in athletes and patients","volume":"14","author":"Loria","year":"2022","journal-title":"Bioanalysis"},{"key":"10.1016\/bs.acc.2026.03.001_bib0083","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5935\/0101-2800.20150039","article-title":"Inflammation and poor response to treatment with erythropoietin in chronic kidney disease","volume":"37","author":"de Oliveira J\u00fanior","year":"2015","journal-title":"J. Bras. Nefrol."},{"key":"10.1016\/bs.acc.2026.03.001_bib0084","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/MNH.0000000000000317","article-title":"Anemia management in chronic kidney disease and dialysis: a narrative review","volume":"26","author":"Collister","year":"2017","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"1","key":"10.1016\/bs.acc.2026.03.001_bib96","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0031-3955(16)34972-0","article-title":"Anemia of Prematurity: Current Concepts in the Issue of When to Transfuse","volume":"33","author":"Stockman","year":"1986","journal-title":"Pedi. Clin.. North America"},{"key":"10.1016\/bs.acc.2026.03.001_bib0085","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mce.2017.01.033","article-title":"Erythropoietin as a performance-enhancing drug: its mechanistic basis, detection, and potential adverse effects","volume":"464","author":"Salamin","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/bs.acc.2026.03.001_bib0086","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2141.1995.tb08909.x","article-title":"Efficacy of erythropoietin in the myelodysplastic syndromes: a meta-analysis of 205 patients from 17 studies","volume":"89","author":"Hellstr\u00f6m-Lindberg","year":"1995","journal-title":"Br. J. Haematol."},{"key":"10.1016\/bs.acc.2026.03.001_bib0087","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1007\/s12325-025-03208-5","article-title":"Long-term transfusion independence with luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, lower-risk myelodysplastic syndromes in the COMMANDS trial","volume":"42","author":"Garcia-Manero","year":"2025","journal-title":"Adv. Ther."},{"key":"10.1016\/bs.acc.2026.03.001_bib0088","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.resp.2016.02.001","article-title":"Effects of erythropoietin on systemic hematocrit and oxygen transport in the splenectomized horse","volume":"225","author":"McKeever","year":"2016","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/bs.acc.2026.03.001_bib0089","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/dta.146","article-title":"Blood cells RNA biomarkers as a first long-term detection strategy for EPO abuse in horseracing","volume":"2","author":"Bailly-Chouriberry","year":"2010","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0090","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.3390\/genes12121874","article-title":"Transcriptomic markers of recombinant human erythropoietin micro-dosing in thoroughbred horses","volume":"12","author":"Dahlgren","year":"2021","journal-title":"Genes"},{"key":"10.1016\/bs.acc.2026.03.001_bib0091","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/dta.3812","article-title":"New transcriptomic biomarkers for detection of the recombinant human erythropoietin (rHuEPO) MirCERA in horses","volume":"17","author":"Loup","year":"2025","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0092","article-title":"Transcriptomic biomarkers in blood indicative of the administration of recombinant human erythropoietin to thoroughbred horses","author":"Cheung","year":"2025","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0093","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/dta.2204","article-title":"RNA sample preparation applied to gene expression profiling for the horse biological passport","volume":"9","author":"Bailly-Chouriberry","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0094","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/dta.3047","article-title":"miRNAs detection in equine plasma by quantitative polymerase chain reaction for doping control: assessment of blood sampling and study of eca-miR-144 as potential erythropoiesis stimulating agent biomarker","volume":"14","author":"Loup","year":"2022","journal-title":"Drug Test. Anal."},{"key":"10.1016\/bs.acc.2026.03.001_bib0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914515","article-title":"Identification of potential miRNA biomarkers to detect hydrocortisone administration in horses","volume":"24","author":"Kikuchi","year":"2023","journal-title":"Int. J. Mol. Sci."}],"container-title":["Advances in Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242326000363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242326000363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T12:55:08Z","timestamp":1782737708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065242326000363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443471001"],"references-count":96,"URL":"https:\/\/doi.org\/10.1016\/bs.acc.2026.03.001","relation":{},"ISSN":["0065-2423"],"issn-type":[{"value":"0065-2423","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}